Extrawell Pharmaceutical Holdings Limited is a Hong Kong-based investment holding company principally engaged in the trading of pharmaceutical products. The Company mainly operates through three segments. The Manufacturing segment is engaged in the development, manufacture and sales of pharmaceutical products. Its manufactured products include Transfer Factor Oral Solution, Wisk and ZhouBang, among others. The Trading segment is engaged in the marketing and distribution of imported pharmaceutical products. Its imported products include GM 1, Millibar and Skin Cap. The Gene Development segment is engaged in the commercial exploitation and development of genome-related technologies.